Matinas BioPharma Holdings Inc (MTNB)
0.6003
-0.03
(-5.38%)
USD |
NYAM |
Nov 15, 12:47
Matinas BioPharma Holdings Free Cash Flow (Quarterly): -3.106M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -3.106M |
March 31, 2024 | -5.769M |
December 31, 2023 | -4.579M |
September 30, 2023 | -4.435M |
June 30, 2023 | -2.395M |
March 31, 2023 | -4.087M |
December 31, 2022 | -4.341M |
September 30, 2022 | -5.22M |
June 30, 2022 | -5.186M |
March 31, 2022 | -5.301M |
December 31, 2021 | -3.993M |
September 30, 2021 | -5.974M |
June 30, 2021 | -0.8647M |
March 31, 2021 | -4.651M |
December 31, 2020 | -4.308M |
September 30, 2020 | -5.227M |
June 30, 2020 | -3.169M |
March 31, 2020 | -4.670M |
December 31, 2019 | -4.899M |
September 30, 2019 | -4.147M |
June 30, 2019 | -2.415M |
March 31, 2019 | -3.038M |
December 31, 2018 | -2.619M |
Date | Value |
---|---|
September 30, 2018 | -2.913M |
June 30, 2018 | -2.417M |
March 31, 2018 | -2.908M |
December 31, 2017 | -2.034M |
September 30, 2017 | -2.819M |
June 30, 2017 | -4.517M |
March 31, 2017 | -3.032M |
December 31, 2016 | -2.116M |
September 30, 2016 | -1.366M |
June 30, 2016 | -1.094M |
March 31, 2016 | -1.543M |
December 31, 2015 | -1.140M |
September 30, 2015 | -2.173M |
June 30, 2015 | -2.250M |
March 31, 2015 | -2.328M |
December 31, 2014 | -2.416M |
September 30, 2014 | -1.641M |
June 30, 2014 | -1.911M |
March 31, 2014 | -2.282M |
December 31, 2013 | -1.732M |
September 30, 2013 | -0.9152M |
June 30, 2013 | -0.2845M |
March 31, 2013 | -0.1501M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.974M
Minimum
Sep 2021
-0.8647M
Maximum
Jun 2021
-4.325M
Average
-4.579M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
Equillium Inc | 0.668M |
Tenon Medical Inc | -2.42M |
Alphatec Holdings Inc | -25.22M |
Merck & Co Inc | 8.508B |
Madrigal Pharmaceuticals Inc | -67.76M |